Recent Stories
- Unborn babies 'practise' facial expressions in the womb
- Lancaster leads the way in cyber security bursary scheme
- Physicists gain insight into the UK's biggest killer
- Engineering students make finals of national start-up business competition
- Social media plagued by privacy problems, say researchers
- Lancaster Environment Centre conducts roadside pollution research for BBC
- Lancaster set to receive funding boost to stimulate UK's economy
- Billion-year-old water could hold clues to life on Earth and Mars
- How do we find out about cyber criminals?
- First, carbon footprints... now you can calculate your 'nitrogen footprint'
Predicting Higher Risk for Prostate Cancer
Story supplied by LU Press Office
Cells which look abnormal but are not designated precancerous could help predict a future diagnosis of prostate cancer, according to new research.
These abnormal yet non-cancerous cells - known as high-grade prostatic intraepithelial neoplasia (HGPIN) - carry a high predictive value for future diagnosis of prostate cancer.
The research published in the open access journal BMC Urology has shown that 41.8% of patients whose extended core biopsy led to an initial diagnosis of HGPIN were subsequently diagnosed with prostate cancer.
Dr Frank Martin a senior lecturer from the University's Lancaster Environment Centre , and Paras Singh, Lancashire Teaching Hospitals NHS Foundation Trust, along with their co-workers, conducted a retrospective analysis of the trust's pathology database, investigating the occurrence of prostate cancer in patients initially diagnosed with HGPIN.
They also calculated the risk of developing prostate cancer based on initial levels of prostate serum antigen (PSA), currently used as a diagnostic marker for prostate cancer.
Of 2,192 biopsied patients, there were 88 cases of isolated HGPIN of which 67 patients underwent one or more repeat biopsies. In this repeat-biopsy group, 28 prostate cancer diagnoses were made. Age at first biopsy, higher baseline PSA and higher change in PSA were all predictive of cancer detection on repeat biopsies.
Dr Martin said: "This pioneering research carried out at Lancaster University in collaboration with Lancashire Teaching Hospitals NHS Trust has the potential to improve important clinical decisions when determining an individual's risk of a future prostate cancer diagnosis in men in the UK."
Wed 27 May 2009
Associated Links
Latest News
Unborn babies 'practise' facial expressions in the womb
Researchers from Durham and Lancaster Universities suggest that a foetus's ability to show a "pain" facial expression is a developmental process which could potentially give doctors another index of the health of a foetus.
Story supplied by LU Press Office
Mon 17 June 2013
Lancaster leads the way in cyber security bursary scheme
Lancaster is one of four UK universities selected to take part in an 'industry first' sponsorship initiative encouraging students to take up Masters-level cyber security degrees.
Story supplied by LU Press Office
Mon 10 June 2013
Physicists gain insight into the UK's biggest killer
Cardiovascular disease is the leading cause of death in the UK, accounting for a third of all fatalities through illnesses such as stroke and heart disease.
Story supplied by LU Press Office
Wed 29 May 2013
Engineering students make finals of national start-up business competition
Engineering students Scott Nash, Daniel Richardson and Aaron Aboshio have won the northern heat of the Youth Entrepreneurs Scheme 'Engineering YES' competition for their spin-out renewable energy company Atlantis.
Thu 23 May 2013